李玉华 刘微 刘晴 郭健 张磊 孙美艳
[摘要] 维生素D作为一种多功能激素,参与调节机体的基本生理功能。大量流行病学和Meta分析结果表明,维生素D缺乏与肿瘤的高发病率和不良预后相关。肿瘤并不是独立的存在,它的发生、生长及转移与肿瘤微环境密切相关,因此了解肿瘤微环境中不同成分在肿瘤侵袭和转移中的作用对肿瘤的预防和治疗至关重要。最新研究表明,维生素D可通过干预肿瘤微环境中某些成分(如细胞因子、前列腺素、NF-κB信号通路等)从而抑制肿瘤发生发展。该文将对维生素D通过干预肿瘤微环境从而抑制肿瘤发生发展的作用机制进行综述,为维生素D及其类似物作为未来候选抗肿瘤药物的研究提供参考。
[关键词] 维生素D;肿瘤;细胞因子;血管;脂肪细胞
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2020)10(b)-0195-04
[Abstract] Vitamin D, as a multifunctional hormone, participates in regulating the basic physiological functions of the body. A large number of epidemiological and meta-analysis results show that vitamin D deficiency is related to the high incidence of tumors and poor prognosis. Tumors do not exist independently. Its occurrence, growth and metastasis are closely related to the tumor microenvironment. Therefore, understanding the role of different components in the tumor microenvironment in tumor invasion and metastasis is very important for tumor prevention and treatment. The latest research shows that vitamin D can inhibit the occurrence and development of tumors by interfering with certain components in the tumor microenvironment (such as cytokines, prostaglandins, NF-κB signaling pathways, etc.). This article will review the mechanism of vitamin D inhibiting the occurrence and development of tumors by intervening in the tumor microenvironment, and provide references for future research on vitamin D and its analogues as candidate anti-tumor drugs.
[Key words] Vitamin D; Tumor; Cytokine; Blood vessel; Adipocyte
維生素D是一种脂溶性类固醇衍生物,主要以两种形式存在:维生素D2和维生素D3。维生素D3在肝脏微粒体中被25-羟化酶转化形成25-羟基维生素D [25(OH)D],然后在肾脏中被1α-羟化酶催化成1,25(OH)2D3,1,25(OH)2D3作为典型的类固醇激素,参与调节钙稳态和骨代谢。流行病学结果显示高血清25(OH)D水平与癌症的发病率和不良预后呈负相关[1-3]。Ma等[4]发现高剂量维生素D摄入和高水平血清25(OH)D可分别使结直肠癌的风险降低12%和33%, Ditsch等人[5]对82例乳腺癌患者的VDR表达情况与患者总生存期的关系进行了研究,发现高VDR表达的患者比低VDR表达患者具有更长的生存期。 Kim等[6]针对13项关于维生素D摄入量、血清25(OH)D浓度以及乳腺癌发病率和预后的Meta分析结果显示,维生素D摄入量每增加100 IU/d,乳腺癌的发病率降低2%。……